Drug Discovery by Accelerators Use

Abstract

Today, pharmaceutical manufacturers have very high expectations for the contribution of precise 3D structural information regarding proteins and their complexes that may be obtained using ultra-brilliant synchrotron radiation. These expectations relate to their drug discovery process and to the promise of the actual discovery of innovative drugs in the future.